Tracking and treating tuberculosis in developing countries

October 3, 2012 by Steve Tokar
Adithya Cattamanchi, MD, an assistant adjunct professor at the UCSF School of Medicine, center, poses colleagues in Hanoi, Vietnam, where he's working to improve tuberculosis testing for patients who live too far away to make multiple visits to the health center.

A patient in rural Uganda is diagnosed with tuberculosis (TB), but never begins treatment. In Hanoi, Vietnam, someone with infectious TB might never be diagnosed because the health center where she would go to be tested is too far away.

"Worldwide, only about half the number of that occur every year are actually detected and reported," said Adithya Cattamanchi, MD, a clinician at San Francisco General Hospital and (SFGH) and an assistant adjunct professor at the UCSF School of Medicine.

Cattamanchi is working to address challenges in Uganda and Vietnam by applying techniques of implementation science (ImS) learned through the Training in Clinical Research Program provided by UCSF's Clinical and Translational Science Institute (CTSI). ImS is focused on improving by translating clinical findings into real-world interventions.

To diagnose TB, a obtains a sputum specimen and smears it on a slide. A laboratory technician then examines the specimen under a microscope for evidence of TB. In conventional practice, a minimum of two specimens are required to confirm the diagnosis.

"Traditionally, we collect a specimen when the patient arrives, and then ask them to come back the next day and bring another specimen. Then they come back a third time to get results and start treatment if they're positive. Therein lies the problem," said Cattamanchi, who is also a CTSI KL2 Scholar.

In developing countries such as Uganda, up to half of all patients never come back to the health center after the first visit, because they live too far away and can't afford to take the time to return. "We asked how we could make the process more convenient for patients, so that they could complete testing and ideally begin treatment in one visit," he said. "We thought, what if we collected just one specimen and made two smears on two different slides? It turned out that we achieved the same level of sensitivity as the traditional method, but in one visit."

Cattamanchi and his team, including Luke Davis, an assistant adjunct professor in the UCSF School of Medicine, and Achilles Katamba, a lecturer at Makerere University in Uganda, are now testing several interventions in six Ugandan health centers to improve the quality of TB diagnosis and treatment:

  • One involves same-day microscopy: "We want to know whether same-day microscopy is feasible in rural health centers, and actually results in more patients getting diagnosed with TB and starting TB treatment."
  • Traditional light microscopes are being replaced with LED microscopes: "They're more sensitive, so you can view the slide at lower magnification, which makes it faster for the lab tech to read the smear. Plus, they're battery-powered so they don't depend on electricity."
  • Finally, researchers are providing monthly report cards to clinic workers summarizing performance on quality indicators of TB evaluation: "The clinicians told us that no one was telling them how they were doing, but they had a hunger to know. They are now meeting on their own to decide how to address issues that come up, and we are measuring whether case detection and treatment initiation improve with this simple intervention."
Cattamanchi's work is exactly the sort of challenge that Implementation Science addresses, said Sara Ackerman, PhD, MPH, a medical anthropologist and the ImS program coordinator. "It's about tailoring research methods to the problem and then designing interventions that will bring about meaningful change—not just in individual behavior, but in communities, resources and organizations," she said.

Using Technology in Health Interventions

In Hanoi, Vietnam, while most people have access to neighborhood health posts, TB testing is only available at district health centers. There, Cattamanchi is working with Payam Nahid, MD, MPH, an associate professor in the UCSF School of Medicine; Daniel Fletcher, PhD, a professor of bioengineering at UC Berkeley; and Nguyen Viet Nhung, MD, PhD, vice-director of the Vietnam National Program, to test a cell phone-based LED microscope that will decentralize the process of diagnosis.

"The health post worker collects the specimen, makes the smear, takes pictures of it with the microscope, and sends the images over the wireless network to the microscopist at the district health center, who reads the images and sends a text message with the results," Cattamanchi said.

Potentially, remote microscopy could be used throughout the developing world where wireless telecommunications networks are becoming ubiquitous, he added.

The project is also testing the impact of replacing traditional microscopy at the district health center level with a more sensitive and automated test developed by Cepheid of Sunnyvale, Calif., called GeneXpert, which identifies TB bacilli by their DNA. This type of test could previously only be performed in a developing country at the level of a national laboratory, he said.

"The training I received in implementation science has been essential to my work—specifically, in qualitative research methods, in designing less expensive studies that are still scientifically accurate, and in writing the rather specialized grants for this work," he said.

In support of efforts to apply ImS principles to global health problems, Cattamanchi is also involved in the Global Health Implementation Sciences Working Group managed by the Division of HIV/AIDS at SFGH. The group meets monthly to review ongoing or planned research projects in concert with a methodological expert.

Projects such as these "embody the type of research that we aim to support," said Ralph Gonzales, MD, a professor in the UCSF School of Medicine and director of CTSI's ImS program.

"Identifying barriers to change, employing new methodologies and skills, supporting collaborations, and achieving improvements in health care practices that are sustainable and reproducible in different settings: this is what implementation science is all about," he said.

Explore further: Implementation science links research with real-world practice to improve health

Related Stories

Implementation science links research with real-world practice to improve health

October 3, 2012
Why do medical research findings often fail to reach the people who could benefit from them most? And why are health programs proven to work in one setting frequently unable to achieve success in other places?

Alternative methods of smear collection are effective at diagnosing TB

July 12, 2011
Two studies by a team of researchers led by Luis E. Cuevas and Mohammed Yassin from the Liverpool School of Tropical Medicine and jointly coordinated with Andrew Ramsay at WHO-TDR Special Programme for Research and Training ...

Blood tests for active TB not accurate or cost-effective

August 10, 2011
Commercial blood serum antibody tests—widely used in India and other developing countries to diagnose active tuberculosis—are not accurate or cost-effective, according to an analysis by researchers at the Johns ...

XPert MTB/RIF cost effective for TB diagnosis in low- and middle-income settings

November 8, 2011
A study led by Frank Cobelens of the Amsterdam Institute of Global Health and Development, Amsterdam, The Netherlands and colleagues reports on the cost-effectiveness of implementing the Xpert MTB/RIF diagnostic test for ...

Recommended for you

Two Group A Streptococcus genes linked to 'flesh-eating' bacterial infections

September 22, 2017
Group A Streptococcus bacteria cause a variety of illnesses that range from mild nuisances like strep throat to life-threatening conditions including pneumonia, toxic shock syndrome and the flesh-eating disease formally known ...

Residents: Frontline defenders against antibiotic resistance?

September 22, 2017
Antibiotic resistance continues to grow around the world, with sometimes disastrous results. Some strains of bacteria no longer respond to any currently available antibiotic, making death by infections that were once easily ...

Ecosystem approach makes urinary tract infection more treatable

September 22, 2017
The biological term 'ecosystem' is not usually associated with urinary tract infections, but this should change according to Wageningen scientists.

Investigators may unlock mystery of how staph cells dodge the body's immune system

September 21, 2017
For years, medical investigators have tried and failed to develop vaccines for a type of staph bacteria associated with the deadly superbug MRSA. But a new study by Cedars-Sinai investigators shows how staph cells evade the ...

Superbug's spread to Vietnam threatens malaria control

September 21, 2017
A highly drug resistant malaria 'superbug' from western Cambodia is now present in southern Vietnam, leading to alarming failure rates for dihydroartemisinin (DHA)-piperaquine—Vietnam's national first-line malaria treatment, ...

Individualized diets for irritable bowel syndrome better than placebo

September 21, 2017
Patients with irritable bowel syndrome who follow individualized diets based on food sensitivity testing experience fewer symptoms, say Yale researchers. Their study is among the first to provide scientific evidence for this ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.